Marta
Santisteban Eslava
Consultora Médica
University Hospital of Geneva
Ginebra, SuizaPublicaciones en colaboración con investigadores/as de University Hospital of Geneva (1)
2021
-
Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis
European Journal of Cancer, Vol. 152, pp. 68-77